Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-04

Clinical Trial Update: Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluates the combination of metronomic oral vinorelbine and sorafenib in adults with advanced non-small cell lung cancer. The study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Navelbine (vinorelbine)
  • Nexavar (Sorafenib)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED